Orizo Pharma Private Limited
About Orizo Pharma Private Limited
Data last updated:
Orizo Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 January 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2022PTC158573.
The company has an authorised share capital of ₹1.7 Cr and a paid-up capital of ₹1.7 Cr. It is led by directors including Zubin Keki Gandhi and Yatin Kirtanlal Desai.
Its last annual general meeting (AGM) was held on 30 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
Company details
Contact details
Orizo Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 201 P.No. 76, Lotus Residency Ayyapa Society, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Orizo Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Orizo Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Orizo Pharma Private Limited, buy the company report.
Board of directors of Orizo Pharma Private Limited
Orizo Pharma has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Zubin Keki Gandhi Also directs: Difgen Pharmaceuticals Private Limited, Venus Ethoxyethers Pvt Ltd, Grand Organics Private Limited and 4 more | Director | 24 May 2023 | 3 Years 5 Months | Current |
| Yatin Kirtanlal Desai Also directs: Difgen Pharmaceuticals Private Limited | Director | 24 May 2023 | 3 Years 5 Months | Current |
| Punit Chunilal Thakrar Also directs: Difgen Pharmaceuticals Private Limited, Polydrug Laboratories LLP | Director | 24 May 2023 | 3 Years 5 Months | Current |
| Amol Ashok Walke Also directs: Difgen Pharmaceuticals Private Limited, Walke Enterprises Limited Liability Partnership, Venus Ethoxyethers Pvt Ltd and 5 more | Director | 24 May 2023 | 3 Years 5 Months | Current |
Auditor
Orizo Pharma Private Limited is audited by D. A. Shinde & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D. A. Shinde & Co. | FY 2023 | 115243W |
Shareholding
The shareholding of Orizo Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Orizo Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Orizo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orizo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Orizo Pharma Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
No GST registration is on our record for Orizo Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Orizo Pharma Private Limited has 12 board changes on record since 2022: 4 appointments and 8 cessations. The latest: Amol Ashok Walke ceased to be Additional Director on 29 Sep 2023.
3 earlier events are in the company report.
Frequently asked questions
Orizo Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 January 2022 (4+ years old) and is registered under CIN U24290TG2022PTC158573.
Orizo Pharma has 4 current directors:
- Zubin Keki Gandhi - Director
- Yatin Kirtanlal Desai - Director
- Punit Chunilal Thakrar - Director
- Amol Ashok Walke - Director
The latest financial statements of Orizo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 August 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Orizo Pharma is U24290TG2022PTC158573. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orizo Pharma was incorporated on 06 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Amol Ashok Walke ceased to be Additional Director on 29 Sep 2023. Punit Chunilal Thakrar ceased to be Additional Director on 29 Sep 2023. Yatin Kirtanlal Desai ceased to be Additional Director on 29 Sep 2023. Orizo Pharma has 12 board changes on record in total.
The registered office of Orizo Pharma is at Flat No. 201 P.No. 76, Lotus Residency Ayyapa Society, Hyderabad, Telangana, India – 500081.
Orizo Pharma operates in the pharma industry, in the drug formulation and development segment.
Orizo Pharma can be reached at its registered office: Flat No. 201 P.No. 76, Lotus Residency Ayyapa Society, Hyderabad, Telangana, India – 500081.
Orizo Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.